Leukemia & MDS
“Leukemia & MDS” was moderated byÂ
— 6 October, 2022
Cantor News
Page 10
Drug Development for Blood Disorders
“Drug Development for Blood Disorders”
— 6 October, 2022
Tackling the Tumor Microenvironment & Further Arming the Immune System
“Tackling the Tumor Microenvironment
— 6 October, 2022
Fireside Chat - Cantor Fitzgerald’s Neurology & Psychiatry Conference
Cantor’s 2022 brain week continues
— 6 October, 2022
Fireside Chat - Cantor Fitzgerald’s Neurology & Psychiatry Conference
Managing Director and Senior Biotech
— 6 October, 2022
Cell Therapy in Solid Tumors
“Cell Therapy in Solid Tumors”
— 5 October, 2022
Trends and Challenges in Immuno-Oncology
“Trends and Challenges in Immuno-Oncology”
— 5 October, 2022
Resistant to Resistance: Approaches to Address Resistance in Oncology
“Resistant to Resistance: Approaches
— 5 October, 2022
Companies with Key Catalysts Over the Next 12-18 Months
— 4 October, 2022
Building Combinations: What are the Novel Ideas?
“Building Combinations: What are
— 4 October, 2022
Predictive Biomarkers, Sequencing, and Diagnostics, Oh My!
“Predictive Biomarkers, Sequencing,
— 4 October, 2022
Innovation is the Name of the Game: Novel Modalities for Oncology
“Innovation is the Name of the Game:
— 3 October, 2022